Sign up to save your podcasts
Or
Share Ticiana Leal, MD - Inspiring Improved Outcomes in Advanced NSCLC: A Patient-Centered Approach to Integrating Combination Locoregional and Immunotherapy Into Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ticiana Leal, MD - Inspiring Improved Outcomes in Advanced NSCLC: A Patient-Centered Approach to Integrating Combination Locoregional and Immunotherapy Into Care
Please visit answersincme.com/TSM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the rationale, latest evidence, and practical considerations for adding a locoregional approach (eg, tumor-treating fields therapy, stereotactic body radiation therapy) to systemic immunotherapy for patients with advanced non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be better able to: Outline the mechanisms of action of novel locoregional therapies and their combination with immunotherapies to treat advanced NSCLC; Describe the evidence on combining novel locoregional therapies with systemic; Immunotherapy for advanced NSCLC; and Identify practical patient-centered strategies for the evidence-based use of combined locoregional and systemic immunotherapy treatment in advanced NSCLC.
View all episodes
By Answers in CME
5
55 ratings
Please visit answersincme.com/TSM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the rationale, latest evidence, and practical considerations for adding a locoregional approach (eg, tumor-treating fields therapy, stereotactic body radiation therapy) to systemic immunotherapy for patients with advanced non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be better able to: Outline the mechanisms of action of novel locoregional therapies and their combination with immunotherapies to treat advanced NSCLC; Describe the evidence on combining novel locoregional therapies with systemic; Immunotherapy for advanced NSCLC; and Identify practical patient-centered strategies for the evidence-based use of combined locoregional and systemic immunotherapy treatment in advanced NSCLC.
More shows like CME in Minutes: Education in Oncology & Hematology
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
324 Listeners
Journal of Clinical Oncology (JCO) Podcast
38 Listeners
This Week in Cardiology
862 Listeners
JAMA Clinical Reviews
493 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
JAMA Medical News
87 Listeners
CME in Minutes: Education in Cardiology & Pulmonology
3 Listeners
CME in Minutes: Education in Dermatology
3 Listeners
CME in Minutes: Education in Primary Care
5 Listeners
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
4 Listeners
CME in Minutes: Education in Ophthalmology
0 Listeners